— First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET…
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell”…
TITUSVILLE, Fla., Jan. 13, 2026 /PRNewswire/ -- Patients of Parrish Medical Center and Parrish Healthcare will see a series of benefits…
PALO ALTO, Calif., Jan. 13, 2026 /PRNewswire/ -- RISA Labs, a company pioneering an AI operating system for oncology, today…
Since 2018, more than $40 million has been granted to support outstanding cancer research projects by early-career scientistsNEW YORK, Jan.…
The Atlas will enable the validation of genetic targets and training of AI models at unprecedented scale SAN DIEGO, Jan.…
Sixth year of training and education support reinforces long-term commitment to firefighter healthTAMPA, Fla., Jan. 13, 2026 /PRNewswire/ -- In…
SAN FRANCISCO and NIJMEGEN, Netherlands, Jan. 13, 2026 /PRNewswire/ -- Ferrum Health will offer Transpara solutions through its Model Hub,…
– Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation anthracycline demonstrates safety and promising…
CEO Highlights Significant Progress Achieved & Outlines Ambitious Plans for 2026MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma,…